Simple measures to monitor β-cell mass and assess islet graft dysfunction

American Journal of Transplantation

Volumn 7, Issue 2, 2007, Pages 303-308

  Faradji, R N ^a   Monroy, K ^a   Messinger, S ^a   Pileggi, A ^a   Froud, T ^a   Baidal, D A ^a   Cure, P E ^a   Ricordi, C ^a   Luzi, L ^a,b   Alejandro, R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

cell mass; C peptide; Graft dysfunction; Insulin independence; Islet transplantation

Indexed keywords

C PEPTIDE; GLUCOSE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; MALE; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; PROTEIN SECRETION; ROC CURVE;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CREATININE; FEMALE; GRAFT REJECTION; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846216746     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01620.x     Document Type: Article

References (20)

1. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004; 47: 943-956.
2. Palmer JP, Fleming GA, Greenbaum CJ et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004; 53: 250-264.
3. Alejandro R, Lehmann R, Ricordi C et al. Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 1997; 46: 1983-1989.
4. Greenbaum CJ, Harrison LC. Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes. Diabetes 2003; 52: 1059-1065.
5. Ryan EA, Lakey JR, PatyBWet al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148-2157.
6. Ryan EALJ, Paty BW et al. Beta-score - An assessment of beta-cell function after islet transplantation. Diabetes Care 2005; 28: 343-347.
7. Secchi A, Pontiroli AE, Traeger J et al. Amethod for early detection of graft failure in pancreas transplantation. Transplantation 1983; 35: 344-348.
8. Matsumoto S, Yamada Y, Okitsu T et al. Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc 2005; 37: 3435-3437.
9. Yamada Y, Fukuda K, Fujimoto S et al. SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract 2006; 74: 222-226.
10. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
11. Zerbini G, Mangili R, Luzi L. Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications. Diabet Med 1999; 16: 1048.
12. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: miami experience. Am J Transplant 2005; 5: 2037-2046.
13. Pileggi ARC, Kenyon NS, Froud T et al. Twenty years of clinical islet transplantation at the Diabetes Research institute-University of Miami. In: Cecka JM, Terasaki PI (eds). Clinical transplants. Los Angeles: UCLA Immunogenetics Center, 2004: 1-28.
14. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
15. Ichii H, Pileggi A, Molano RD et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 2005; 5: 21-30.
16. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
17. Teuscher A, Kendall D, Smets Y, Leone J, Sutherland D, Robertson R. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47: 324-330.
18. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997; 53: 567-578.
19. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51(Suppl 1): S212-220.
20. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab 2004; 287: E637-E643.